HOUSTON, TX , a leading provider of employee screening solutions and canine security and surveillance services, announced today that it has entered into an alliance agreement with Global Medical Testing (Houston, Texas) to develop a client base, initially in the energy industries, that utilizes the cross selling of both companies services to promote worldwide service delivery while developing an increased revenue base that is profitable to both parties.

LBWR will provide the web-based platform, software, system security, and personnel to support the management and operation of collection of data and manipulation of records to deliver fully compliant services to the client.

GMT will manage the specimen collection process, education/certification of personnel, staffing of personnel (where appropriate), and training as required to deliver compliant services to the client.

"We are very excited about this development and the opportunity it affords Labwire to address larger energy providers through their international operational needs," commented Mr. Dexter Morris, Chairman and Chief Executive Officer of Labwire. "International services that report back to and are controlled by U.S.-based operational managers have been a continual source of concern to the Industry for several years. By combining Labwire's web-based delivery platform and Global's field experience we now have a workable solution to answer these needs."

"Global Medical Testing is extremely excited at the opportunity to expand its specialized services with the web-based platform services of Labwire. GMT is certain that the alliance with Labwire will complete the first cohesive arrangement for coordinated and compliant drug and alcohol testing services in the US and worldwide," said Janet Jordan, President and CEO of GMT.

About Labwire

Labwire Inc., Headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations via the Labwire(TM) Platform. Labwire(TM) is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry.

About Global Medical

Janet Jordan RN, BSN President and CFO of Global Medical Testing (GMT), has been providing drug and alcohol testing/collection services since 1989. GMT is known for their vigilant compliance standards and their provision of alternatives to the ever-changing environment of drug testing in the work place.

GMT's senior management received extensive experience in International specimen collections while acting as collections specialists under the stringent compliance of the International Tennis Federation (ITF) anti-doping program. GMT is one of only a limited number of companies qualified to provide compliant offshore services.

Safe Harbor Provisions:

Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by Labwire, Inc., (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements, including those in Management's Discussion and Analysis, are statements regarding the intent, belief or current expectations, estimates or projections of the Company, its Directors or its Officers about the Company and the industry in which it operates, and are based on assumptions made by management. Forward looking statements include without limitation statements regarding: (a) the Company's strategies regarding growth and business expansion, including future acquisitions; (b) the Company's financing plans; (c) trends affecting the Company's financial condition or results of operations; (d) the Company's ability to continue to control costs and to meet its liquidity and other financing needs; (e) the declaration and payment of dividends; and (f) the Company's ability to respond to changes in customer demand and regulations. Although the Company believes that its expectations are based on reasonable assumptions, it can give no assurance that the anticipated results will occur. When issued in this report, the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are generally intended to identify forward-looking statements.

Important factors that could cause the actual results to differ materially from those in the forward-looking statements include, among other items, (i) changes in the regulatory and general economic environment; (ii) conditions in the capital markets, including the interest rate environment and the availability of capital; (iii) changes in the competitive marketplace that could affect the Company's revenue and/or cost and expenses, such as increased competition, lack of qualified marketing, management or other personnel, and increased labor and inventory costs; (iv) changes in technology or customer requirements, which could render the Company's technologies noncompetitive or obsolete; (v) new product introductions, product sales mix and the geographic mix of sales.

The Company disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this advertisement are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, governmental approval processes, the impact of competitive products or pricing, technological changes, and the effect of economic conditions.

Contact: Investors & Public Relations Marlin R. Williford Jr. email: mwilliford@capnetrisk.com phone: (832) 487-7803

Labwire (CE) (USOTC:LBWR)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Labwire (CE)
Labwire (CE) (USOTC:LBWR)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Labwire (CE)